A citation-based method for searching scientific literature

P M Ridker, N Rifai, M J Stampfer, C H Hennekens. Circulation 2000
Times Cited: 1750







List of co-cited articles
539 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
32

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
637
22

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
819
17

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
Nadeem Sarwar, Adam S Butterworth, Daniel F Freitag, John Gregson, Peter Willeit, Donal N Gorman, Pei Gao, Danish Saleheen, Augusto Rendon, Christopher P Nelson,[...]. Lancet 2012
500
15

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
526
14


Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
Ola Kleveland, Gabor Kunszt, Marte Bratlie, Thor Ueland, Kaspar Broch, Espen Holte, Annika E Michelsen, Bjørn Bendz, Brage H Amundsen, Terje Espevik,[...]. Eur Heart J 2016
168
13

Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
384
12

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Pei Gao, Daniel F Freitag, Adam S Butterworth, Anders Borglykke, Emanuele Di Angelantonio, Vilmundur Gudnason, Ann Rumley, Gordon D O Lowe,[...]. Eur Heart J 2014
339
11

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
219
11


Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
10

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
10

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
9



C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Stephen Kaptoge, Emanuele Di Angelantonio, Gordon Lowe, Mark B Pepys, Simon G Thompson, Rory Collins, John Danesh. Lancet 2010
9


Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
468
9

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
A D Pradhan, J E Manson, N Rifai, J E Buring, P M Ridker. JAMA 2001
8

Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
Bernhard Schieffer, Tina Selle, Andres Hilfiker, Denise Hilfiker-Kleiner, Karsten Grote, Uwe J F Tietge, Christian Trautwein, Maren Luchtefeld, Christian Schmittkamp, Sylvia Heeneman,[...]. Circulation 2004
222
8


Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.
P M Ridker, N Rifai, M Pfeffer, F Sacks, S Lepage, E Braunwald. Circulation 2000
723
7

C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Gérald Luc, Jean-Marie Bard, Irène Juhan-Vague, Jean Ferrieres, Alun Evans, Philippe Amouyel, Dominique Arveiler, Jean-Charles Fruchart, Pierre Ducimetiere. Arterioscler Thromb Vasc Biol 2003
285
7



All roads lead to IL-6: A central hub of cardiometabolic signaling.
Peter Libby, Viviane Zorzanelli Rocha. Int J Cardiol 2018
24
25

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.
Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H Solomon, Miguel A Hernán, Paul M Ridker, Dariush Mozaffarian. Am J Cardiol 2011
330
6

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Camille Roubille, Vincent Richer, Tara Starnino, Collette McCourt, Alexandra McFarlane, Patrick Fleming, Stephanie Siu, John Kraft, Charles Lynde, Janet Pope,[...]. Ann Rheum Dis 2015
461
6

Interleukin-6 exacerbates early atherosclerosis in mice.
S A Huber, P Sakkinen, D Conze, N Hardin, R Tracy. Arterioscler Thromb Vasc Biol 1999
399
6


Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
Michelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, Philip E Aylward, Marc P Bonaca, Andrzej Budaj, Richard Y Davies, Mikael Dellborg, Keith A A Fox, Jorge Antonio T Gutierrez,[...]. JAMA 2016
144
6


Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice.
Harald Schuett, René Oestreich, Georg H Waetzig, Wijtske Annema, Maren Luchtefeld, Anja Hillmer, Udo Bavendiek, Johann von Felden, Dimitar Divchev, Tibor Kempf,[...]. Arterioscler Thromb Vasc Biol 2012
151
5

Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability.
Z Mallat, A Corbaz, A Scoazec, S Besnard, G Lesèche, Y Chvatchko, A Tedgui. Circulation 2001
430
5

Immunity and Inflammation in Atherosclerosis.
Dennis Wolf, Klaus Ley. Circ Res 2019
356
5

Inflammation and metabolic disorders.
Gökhan S Hotamisligil. Nature 2006
5

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.
Juan Antonio Avina-Zubieta, Jamie Thomas, Mohsen Sadatsafavi, Allen J Lehman, Diane Lacaille. Ann Rheum Dis 2012
502
5

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.
J Antonio Aviña-Zubieta, Hyon K Choi, Mohsen Sadatsafavi, Mahyar Etminan, John M Esdaile, Diane Lacaille. Arthritis Rheum 2008
890
5

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
5

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
Hyon K Choi, Miguel A Hernán, John D Seeger, James M Robins, Frederick Wolfe. Lancet 2002
831
5

Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
Christina L Fanola, David A Morrow, Christopher P Cannon, Petr Jarolim, Mary Ann Lukas, Christoph Bode, Judith S Hochman, Erica L Goodrich, Eugene Braunwald, Michelle L O'Donoghue. J Am Heart Assoc 2017
66
7

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Claes Held, Harvey D White, Ralph A H Stewart, Andrzej Budaj, Christopher P Cannon, Judith S Hochman, Wolfgang Koenig, Agneta Siegbahn, Philippe Gabriel Steg, Joseph Soffer,[...]. J Am Heart Assoc 2017
105
5



Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.
B Schieffer, E Schieffer, D Hilfiker-Kleiner, A Hilfiker, P T Kovanen, M Kaartinen, J Nussberger, W Harringer, H Drexler. Circulation 2000
512
5

Recent advances on the role of cytokines in atherosclerosis.
Hafid Ait-Oufella, Soraya Taleb, Ziad Mallat, Alain Tedgui. Arterioscler Thromb Vasc Biol 2011
371
5

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers,[...]. Circulation 2003
5

Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice.
Delphine Gomez, Richard A Baylis, Brittany G Durgin, Alexandra A C Newman, Gabriel F Alencar, Sidney Mahan, Cynthia St Hilaire, Werner Müller, Ari Waisman, Sheila E Francis,[...]. Nat Med 2018
115
5

Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
Hirokazu Kirii, Tamikazu Niwa, Yasuhiro Yamada, Hisayasu Wada, Kuniaki Saito, Yoichiro Iwakura, Masahide Asano, Hisataka Moriwaki, Mitsuru Seishima. Arterioscler Thromb Vasc Biol 2003
533
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.